C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinicopathologic correlation
- 1 April 1998
- journal article
- Published by Elsevier in Human Pathology
- Vol. 29 (4) , 323-329
- https://doi.org/10.1016/s0046-8177(98)90111-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST piBritish Journal of Cancer, 1996
- The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerHuman Pathology, 1996
- The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 casesBreast Cancer Research and Treatment, 1995
- Immunohistochemical detection ofHER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosisCancer, 1995
- What's New in Breast Cancer?: Molecular Perspectives of Cancer Development and the Role of the Oncogene c-erbB-2 in Prognosis and DiseasePathology - Research and Practice, 1993
- Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?Human Pathology, 1993
- Prognostic significance of c-erbB-2 expression in node negative breast cancerBritish Journal of Cancer, 1993
- Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila developmentNature, 1989
- A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency TablesJournal of the American Statistical Association, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958